Chemical Structure (Cyklokapron 01)
Cyklokapron Injection, Solution
Product Images NDC 0013-1114
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyklokapron (NDC 0013-1114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Cyklokapron 02)
This is a product promotion for "Injectables" by Plizer Labs, which is a division of Pfizer Inc, located in New York.*
Principal Display Panel (10 mL Ampule Label)
This is a description of an injectable drug called "Cyklokapron" which contains 1000mg of tranexamic acid per 10ml ampule. The drug is indicated for intravenous use only and should be administered via a single-dose ampule. The unused portion of the drug should be discarded. The drug is manufactured by Piizer Labs and the National Drug Code (NDC) is 0013-1114-01. This product is distributed in New York, NY 10017.*
Principal Display Panel (10 mL Ampule Carton)
This is a medication called Cyklokapron also known as Tranexamic acid. It comes in a single-dose ampule of 10 mL containing 1000 mg/10 mL (100 mg/mL) of the solution for intravenous injection. The medication should be discarded after a single use and stored at a temperature between 15°C-30°C (50°F-86°F). The medication comes with prescription information which specifies the dosage and use. The ampule is manufactured in Japan and distributed by Phamacia & Upjohn Co, a division of Pfizer, Inc in New York City.*
Principal Display Panel (10 mL Ampule Carton)
Cyklokapron® is a tranexamic acid injection for intravenous use. It comes in a 10mL single-dose ampule containing 1,000mg/10mL (100mg/mL) of tranexamic acid. The product should be stored at room temperature (15°-30°C / 59°-86°F) and should be discarded if not used entirely. Made in Japan and distributed by Pfizer Labs. Dosage and use should be consulted with the accompanying documentation. Lot/exp/sn information is provided.*
Principal Display Panel (10 x 10 mL Ampule Box Label)
Cyklokapron is a solution for intravenous injection used as a single dose containing 1000 mg/10 mL (100 mg/mL) of tranexamic acid. Each ampule contains 1 g tranexamic acid. It is distributed by Pharmacia & Upjohn Co, Division of Pfizer Inc, NY. The drug should be stored at 25°C (77°F), and excursions to 15°-30°C (50°-86°F) are permitted. The product is for Rx only and the prescribing information should be read before use. The text also includes NDC and PAA number as well as manufacturing information.*
Principal Display Panel (10 mL Vial Label)
Cyklokapron® is an injection medication containing tranexamic acid used for intravenous use only. It comes in a single-dose vial and contains 1,000 mg of tranexamic acid per 10 mL of solution (100 mg/mL). The product should be discarded if any portion remains unused. The medication is distributed by Pfizer Labs, a division of Pfizer Inc. located in New York, NY 10017.*
Principal Display Panel (10 mL Vial Box)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
